Hyaluronic Acid in Australia
Hyaluronic Acid in Australia section, includes general infrmation about Hyaluronic Acid Procedure, Hyaluronic Acid Australia Local News, Hyaluronic Acid Australia Surgeon Locator and other Hyaluronic Acid related material.
Hyaluronic Acid Procedure
Injectable fillers are one of the most popular facial rejuvenation techniques. As we age, the underlying tissues that keep our skin looking youthful and firm begin to break down due to the effects of gravity, sun exposure, diet, genetic factors, and years of facial muscle movement. Over time these factors contribute to the development of lines, wrinkles, and folds in the face.
Your skin consists of two layers known as the epidermis and the dermis. The epidermis, or outer layer of the skin, acts as the skin’s primary defense against the environment. The dermis, or innermost layer of the skin, is composed primarily of connective tissue and provides the skin with a support network. Most facial wrinkles and deeper folds occur within the dermal layer of the skin.
Within the connective tissue of the dermis, collagen and elastin fibers form a network that provides the skin with structure, support, and elasticity. Furthermore, fat cells and other molecules, such as hyaluronic acid, help to create volume beneath facial skin. With time, this network of collagen and elastin fibers breaks down, and hyaluronic acid molecules and fat cells that create volume are depleted. Together breakdown and depletion of these molecules result in wrinkles and other changes to facial skin.
When used as standalone treatments or with other procedures, injectable fillers can reduce or eliminate wrinkles and scars, create fuller lips, and treat lipoatrophy, or fat loss beneath the skin. With little downtime and almost immediate results, injectable fillers offer a safe, effective method of restoring a smoother, more youthful appearance.
Hyaluronic acid is a naturally occurring complex sugar molecule that forms large matrices in the connective tissue of the body, such as skin and cartilage. Much like a sponge, its primary function is to bind and absorb water molecules, which creates volume in the face. Hyaluronic acid fillers are generally used to treat facial wrinkles and folds and to enhance the appearance of the lips. One of the fastest growing dermal filler treatments available, hyaluronic acid fillers work by replacing the hyaluronic acid in the body that has depleted over time, which restores the volume beneath the skin’s surface.
While there are a variety of hyaluronic acid fillers, some of the most common are Hylaform®, Restylane®, and Juvederm®. Hylaform®, marketed by INAMED Aesthetics, consists of avian, or bird-derived, hyaluronic acid. Restylane®, marketed by Medicis, and Juvederm®, marketed by Allergan, are both non-animal derived forms of hyaluronic acid produced in the laboratory. Hyaluronic acid fillers are generally biocompatible, which means allergy skin testing is not required prior to treatment.
Depending on the extent of treatment, hyaluronic acid injection procedures typically last between fifteen and sixty minutes. Prior to the start of your procedure, the treatment areas will be cleansed, usually using an alcohol based cleaner. Unlike collagen injections, hyaluronic acid injections do not include an anesthetic agent. Therefore, a local or topical anesthetic may be used to numb the treatment area during the procedure.
Using an ultra fine needle, hyaluronic acid is injected into the dermis at several points along the edge of the treatment area. After approximately two to three injections, the physician will massage the treatment area. The physician will continue injecting the filler along the length of the wrinkle or fold until maximum correction has been achieved. If a local anesthesia has not been used, you may feel some minor stinging from the injections. As the injected hyaluronic acid molecules attract and bind water molecules, the volume beneath the skin will increase, restoring a smoother, more youthful appearance.
Immediately following the injections, you may experience some redness, slight stinging, minor swelling, or bruising in the treatment area. Tiny scabs may also form at the injection sites. These symptoms typically disappear within two to three days. No bandaging is necessary and most patients are able to resume normal activities immediately.
The body will eventually metabolize and absorb the injected hyaluronic acid over time. Therefore, while the effects are immediate, hyaluronic acid injections do not provide the same long-lasting results that may be gained from cosmetic surgery. Although the longevity of results varies by patient, results from hyaluronic acid injections are typically maintained for six to twelve months.
Other Hyaluronic Acid Procedures
All Skin Procedures
Hyaluronic Acid Australia (current)
Hyaluronic Acid Australia Chemical Peel
Hyaluronic Acid Australia Dermabrasion
Hyaluronic Acid Australia Laser Hair Removal
Hyaluronic Acid Australia Collagen Injections
More Australia info...
Australia Economy Australia has a prosperous Western-style capitalist economy, with a per capita GDP on par with the four dominant West European economies. Rising output in the domestic economy has been offsetting the global slump, and business and consumer confidence remains robust. The Federal government's emphasis on reform is another factor behind the economy's strength. The recent upturn in global commodity prices has helped Australia's economy grow since 2000.
While income disparities grew throughout the 80s, especially in outer suburban areas, strong employment growth and mandated minimum conditions for workers ensured that overall living standards kept growing until the 1990s.
Australia Time zones Mainland Australia has three time zones, on account of its large geographical range:
Eastern Standard Time (EST) - operates in New South Wales, the Australian Capital Territory, Victoria, Tasmania and Queensland, 10 hours ahead of Greenwich Mean Time (GMT)
Central Standard Time (CST) - operates in South Australia and the Northern Territory (half an hour behind EST, 9.5 hours ahead of GMT)
Western Standard Time (WST) - operates in Western Australia (two hours behind EST, 8 hours ahead of GMT). Several Australian states observe daylight saving time during the summer season. In NSW, ACT, VIC, SA and WA, daylight savings time applies from the end of October to the end of March and in Tasmania from the beginning of October to the end of March. (In 2006 only, daylight saving begins on December 3 in WA). Queensland and the Northern Territory do not use daylight savings time. Due to the half hour difference between CST and EST, this means that during summer there are five different time zones operating in Australia: GMT+9 (WA), GMT+9.5 (NT), GMT+10 (Qld), GMT+10.5 (SA) and GMT+11 (NSW, ACT, Vic, Tas).
Plastic Surgery News...
Objective To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV).
Design A randomized, double-blind, placebo-controlled study with a crossover arm for those who failed treatment.
Setting A US multicenter outpatient study.
Patients A total of 19 subjects enrolled among 5 centers, 9 randomized to receive dapsone and 10 to receive placebo. Inclusion criteria were biopsy and direct immunofluorescence-proven PV controlled with glucocorticoids and/or cytotoxic agents, disease in maintenance phase, and aged 18 to 80 years. Physicians had tried at least 2 tapers of glucocorticoids unsuccessfully and had 30 days of stable steroid dosage. Treatment for any patient unable to taper glucocorticoids by more than 25% within 4 months was declared a failure, and the patient was allowed to switch to the opposite medication while maintaining the double-blind.
Main Outcome Measure The ability of patients to taper to 7.5 mg/d or less within 1 year of reaching the maximum dosage of the study drug.
Results Of the 9 patients receiving dapsone, 5 were successfully treated, 3 failed treatment, and 1 dropped out of the study. Of the 10 patients receiving placebo, 3 were successfully treated, and 7 failed treatment. This primary end point favored the dapsone-treated group but was not statistically significant (P = .37). Four patients who failed treatment while receiving placebo were switched to treatment with dapsone. Of these, 3 were successfully treated after switching to dapsone treatment, and 1 failed treatment. We found that, overall, 8 of 11 patients (73%) receiving dapsone vs 3 of 10 (30%) receiving placebo reached the primary outcome of a prednisone dosage of 7.5 mg/d or less.
Conclusion This trial demonstrates a trend to efficacy of dapsone as a steroid-sparing drug in maintenance-phase PV.
Trial Registration clinicaltrials.gov Identifier: NCT00429533
- The Bush administration on Friday sent Congress a letter that included 13 proposed spending offsets for the farm bill, such as a reduction in Medicare coverage of certain medical equipment, CQ Today reports. The proposed offsets, which total $22 billion, would allow lawmakers to increase the baseline budget for the legislation by $10 billion over 10 years (Richert, CQ Today, 3/3).